E-mail not displaying correctly? View it in your browser.
Our Products
& Services
Click to find
more about our
 
In this newsletter

New: 3D InSight™ Human Liver Microtissues
InSphero today launched a new product that makes in-vitro drug screening more efficient: 3D InSight™ Human Liver Microtissues - affordable and easy to use. Read more here.


InSphero and Novartis interviewed by Biotechnology Journal
Biotechnology Journal discussed with InSphero and Novartis challenges and perspectives in using 3D cell culture systems. Read more here.


3D cell culture literature picks – June 2012
Our applications team has reviewed a small selection of current 3D-cell-culture journal papers  to keep you updated about recent developments in 3D.

Meet InSphero at fairs & events
Meet the InSphero team at upcoming fairs, conferences and workshops to learn how 3D microtissues accelerate the process of drug discovery and development. Arrange a meeting, a webinar or register for a workshop.
About InSphero
 
InSphero is a leading supplier of organotypic, biological in-vitro 3D microtissues for highly predictive drug testing. The company, headquartered in Zurich, Switzerland, currently counts 6 of the top ten global pharmaceutical and cosmetics companies as customers, and is helping them implement the company’s patent-pending microtissue technology in their development work-flow. InSphero’s 3D microtissues are scaffold free, highly reproducible and delivered in an automation-compatible 96-well format to replace conventional 2D cell assays for better biological relevance and predictivity. The 3D cancer microtissues reflect tumor physiology and are used routinely for screening. For toxicology and metabolics applications, rat and human 3D liver microtissues predict even rare cases of idiosyncratic toxicology and remain viable for more than 5 weeks for chronic studies. InSphero’s off-the-shelf portfolio of assay-ready microtissues is complemented by custom-made 3D microtissues with a development time of 4-6 weeks and production turnaround of less than 10 days.
InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich. The company was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award, CTIstartup certification and the SLAS New Product Award (NPA) 2011 Designation. InSphero is also officially certified to the ISO 9001:2008 standard for its Quality Management System.

Our mailing address is:
InSphero Inc.
74 Orion St
Techplace
Brunswick, ME 04011-5031


Copyright (C) 2012 InSphero Inc. All rights reserved.